Dexamethasone Added to Transversalis Fascia Plane Block in Inguinal Hernia Repair
Perineural Dexamethasone as an Adjuvant to Bupivacaine in Transversalis Fascia Plane Block for Open Inguinal Hernia Repair: A Randomized, Controlled, Double-Blind Study
Transversalis fascia plane (TFP) block is an ultrasound-guided abdominal wall block used for postoperative analgesia after inguinal hernia repair. Perineural dexamethasone prolongs analgesia in peripheral nerve blocks, but its efficacy in fascial plane blocks, where the injectate reaches the nerves by diffusion, is uncertain, and no placebo-controlled randomized trial has addressed this question for the TFP block. This prospective, randomized, controlled, double-blind trial will evaluate whether adding 4 mg dexamethasone to bupivacaine in a TFP block prolongs the time to first analgesic request and reduces rescue analgesic consumption in adult patients undergoing elective unilateral open inguinal hernia repair under spinal anesthesia. Sixty-four patients will be randomized 1:1 to bupivacaine + dexamethasone or bupivacaine + saline.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
Patients scheduled for elective unilateral open inguinal hernia repair under spinal anesthesia (15 mg hyperbaric bupivacaine 0.5%) will be randomized to two groups (n=32 each) using computer-generated random numbers (Research Randomizer). At the end of surgery, a unilateral ultrasound-guided TFP block will be performed (in-plane technique, 21G 100 mm needle, between the transversus abdominis muscle and the transversalis fascia, between the midaxillary line and the iliac crest).
Group D: 20 mL 0.25% bupivacaine + 4 mg (1 mL) dexamethasone. Group K (control): 20 mL 0.25% bupivacaine + 1 mL saline. Total volume is 21 mL in both groups. Study solutions are prepared by an independent anesthesia technician not otherwise involved in the study. The block performer, the postoperative assessor and the patient are blinded to group allocation.
All patients receive 1 g IV paracetamol 20 minutes before the end of surgery and 1000 mg IV paracetamol every 8 hours postoperatively. Rescue analgesia: 50 mg IV dexketoprofen for NRS ≥4 or on patient request; if NRS remains ≥4, 50 mg IV tramadol. Pain (NRS) is assessed at rest and during movement at 2, 4, 8, 12 and 24 hours. Recovery quality is assessed with the Turkish version of the QoR-15 (QoR-15T) preoperatively and at 24 hours. Block-related complications are monitored.
Sample size (G*Power 3.1.9.4; d=0.75, alpha 0.05 two-tailed, power 80%) was 29 per group; increased by 10% for dropouts to 32 per group (N=64). Data will be analyzed with SPSS 23.0 (independent t-test or Mann-Whitney U for continuous variables, chi-square or Fisher's exact test for categorical variables; p<0.05).
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Fatih Balcı
- Telefonnummer: +90 545 864 76 57
- E-mail: fatihbalci05@gmail.com
Studiesteder
-
-
Sivas
-
Merkez, Sivas, Tyrkiet (Türkiye), 58050
- Sivas Numune Hospital, Department of Anesthesiology and Reanimation, Sivas, Turkey
-
Kontakt:
- Fatih Balcı
- Telefonnummer: +905458647657
- E-mail: fatihbalci05@gmail.com
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Age ≥18 years
- ASA physical status I-II
- Elective unilateral open inguinal hernia repair under spinal anesthesia
- Written informed consent
Exclusion Criteria:
- Infection at the block site
- Known allergy or contraindication to local anesthetics or dexamethasone
- History of bleeding diathesis or coagulopathy
- Uncontrolled diabetes mellitus
- Severe cognitive impairment preventing pain assessment (NRS)
- Refusal or inability to give informed consent
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Firedobbelt
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Grup D
TFP block with 20 mL 0.25% bupivacaine + 4 mg (1 mL) dexamethasone (total 21 mL) at the end of surgery. |
4 mg (1 mL) added to bupivacaine in the TFP block. 20 mL 0.25% bupivacaine for the TFP block. |
|
Placebo komparator: Grup K
TFP block with 20 mL 0.25% bupivacaine + 1 mL 0.9% saline (total 21 mL) at the end of surgery. |
20 mL 0.25% bupivacaine for the TFP block. 1 mL 0.9% saline added to bupivacaine as placebo. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Time to first analgesic request
Tidsramme: 24 hours postoperatively
|
Time in minutes from completion of the TFP block to the first request for rescue analgesia (dexketoprofen 50 mg IV), given for NRS ≥4 or on patient request. |
24 hours postoperatively
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
VAS pain score at rest
Tidsramme: 2, 4, 8, 12 and 24 hours postoperatively
|
Pain intensity at rest measured with the Visual Analog Scale (VAS, 0 = no pain, 10 = worst imaginable pain). |
2, 4, 8, 12 and 24 hours postoperatively
|
|
VAS pain score during movement
Tidsramme: 2, 4, 8, 12 and 24 hours postoperatively
|
Pain intensity during movement (coughing or 30° leg raise) measured with the VAS (0-10). |
2, 4, 8, 12 and 24 hours postoperatively
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Publikationer og nyttige links
Generelle publikationer
- Celik HK, Tulgar S, Buk OF, Koc K, Unal M, Genc C, Suren M. Comparison of the analgesic efficacy of the ultrasound-guided transversalis fascia plane block and erector spinae plane block in patients undergoing open inguinal hernia repair under spinal anesthesia. Korean J Anesthesiol. 2024 Apr;77(2):255-264. doi: 10.4097/kja.23404. Epub 2024 Jan 8.
- Hebbard PD. Transversalis fascia plane block, a novel ultrasound-guided abdominal wall nerve block. Can J Anaesth. 2009 Aug;56(8):618-20. doi: 10.1007/s12630-009-9110-1. Epub 2009 Jun 4. No abstract available.
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Smerte
- Neurologiske manifestationer
- Postoperative komplikationer
- Patologiske processer
- Patologiske tilstande, tegn og symptomer
- Tegn og symptomer
- Smerter, postoperativ
- Organiske kemikalier
- Polycykliske forbindelser
- Anilider
- Amider
- Anilinforbindelser
- Aminer
- Uorganiske kemikalier
- Klorforbindelser
- Gravidier
- Graviditet
- Steroider
- SMUSED-RING-forbindelser
- Steroider, fluoreret
- Gravideretrioler
- Natriumforbindelser
- Chlorider
- Hydrochlorsyre
- Dexamethason
- Bupivacain
- Natriumchlorid
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- 2026-05/33 07.05.2026
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
upon reasonable request
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .